Loading clinical trials...
Loading clinical trials...
A Multi-Center, Double-Masked, Vehicle-Controlled, Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (the NEAR-2 Study: Near Eye-vision Acuity Restoration)
Conditions
Interventions
CSF-1
Vehicle
Locations
18
United States
Orasis Investigative Site
Chandler, Arizona, United States
Orasis Investigative Site
Mesa, Arizona, United States
Orasis Investigative Site
Phoenix, Arizona, United States
Orasis Investigative Site
Garden Grove, California, United States
Orasis Investigative Site
Mission Hills, California, United States
Orasis Investigative Site
Newport Beach, California, United States
Start Date
October 26, 2020
Primary Completion Date
January 21, 2022
Completion Date
January 28, 2022
Last Updated
April 4, 2024
NCT06060041
NCT03135327
NCT07051720
NCT06948357
NCT06869044
NCT04465409
Lead Sponsor
Orasis Pharmaceuticals Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions